BIRC5 and neoplasm: When analysing the specificity of CD8+ T cells, we monitored a sizeable antiviral T cell response yet failed to detect a response against multiple epitopes of survivin, an LLC-associated antigen.35 Even more so, up to 50% of the tumour infiltrating lymphocytes were reactive to a single immune-dominant viral epitope.